Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
FARMINGTON, Conn., Dec. 22, 2016 -- Immuron Limited: The latest travel forecast released this week by AAA, projects that 103 million Americans will travel during the December 23, 2016 – January 2, 2017 Holiday Season. Many of those travelers will become ill, or experience intestinal discomfort, from the food they eat along the way.
|
|||
While food-borne, E. coli-based illnesses are certainly of concern during international travel, last year’s largest E. coli outbreak was actually in the United States - at several Chipotle’s restaurants. So it’s important to be prepared to minimize the risk of food/water-borne illness wherever you are traveling, both domestically and abroad.
Travelan is a supplement that was developed by Australian bio-pharmaceutical company, Immuron Ltd., to help protect your intestinal track against the 13 most commonly occurring strains of E. coli*. Popular in its native Australia for the past 10 years, and in Canada for the past three years, Travelan is now available in the United States on CVS.com and in select CVS/pharmacy stores, on Amazon.com, at Passport Health clinics and other travel medical providers.
About Travelan:
- Travelan is a non-prescription supplement uniquely formulated to be high in antibodies that can help support and maintain gastrointestinal and digestive function and health.
- Travelan’s active ingredient is Hyperimmune Bovine Colostrum Powder, which has been specifically engineered to be a rich source of antibodies that bind to Enterotoxigenic E. coli in the gastrointestinal tract, preventing them from attaching to the intestinal wall and thereby neutralizing their ability to cause diarrhea and its associated symptoms.
- Hyperimmune Colostrum is developed under Immuron’s Proprietary Technology to create high titers of antibodies to a range of E. coli bacteria that is present in normal colostrum in only very small amounts.
About Immuron Limited:
Immuron Limited™ is a publicly listed Australian bio-pharmaceutical company (ASX:IMC) focused on oral immunotherapy using polyclonal antibody products. Immuron is a uniquely positioned company developing therapeutic products in NASH (fatty-liver disease), ASH (alcoholic fatty-liver disease) and other diseases mediated through gut dysbiosis.
Visit www.Immuron.com to learn more about the company or www.TravelanUSA.com to learn more about Travelan.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Media Contact: Kathy Kaschuluk [email protected]
